Bioinactive ACTH Causing Glucocorticoid Deficiency
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
CONTEXT: A 4-year-old girl and a 4-month-old boy presented with hypoglycemia, normal electrolytes, low cortisol, and high ACTH. A diagnosis of primary adrenal insufficiency was made and initial treatment was with glucocorticoids and mineralocorticoids. The genes known to cause ACTH resistance were normal. Whole exome sequencing revealed that the girl was compound heterozygous for POMC mutations: one previously described null allele and one novel p.R8C mutation in the sequence encoding ACTH and α-MSH. The boy was homozygous for the p.R8C mutation. HYPOTHESIS: The p.R8C ACTH mutant is immunoreactive, but the mutant peptides, ACTH-R8C and α-MSH-R8C, are bioinactive. METHODS: Methods included whole exome sequencing, Sanger sequencing, peptide synthesis, ACTH immunoradiometric assay, hormone binding, and activation assays in cells expressing melanocortin receptors. RESULTS: ACTH-R8C was immunoreactive but failed to bind and activate cAMP production in melanocortin-2 receptor (MC2R)-expressing cells, and α-MSH-R8C failed to bind and stimulate cAMP production in MC1R- and MC4R-expressing cells. CONCLUSION: These are the first documented cases of glucocorticoid deficiency due to the secretion of an ACTH molecule that lacks biological bioactivity but conserves immunoreactivity. POMC mutations should thus be considered in patients presenting with apparent ACTH resistance. Our findings also highlight a limitation to immunoassay-based diagnostics and demonstrate the value of genetic analysis. Establishing the molecular etiology of the disorder in our patients allowed cessation of the unnecessary mineralocorticoids. Finally, discovery of this mutation indicates that in humans, the amino acid sequence His(6)Phe(7)Arg(8)Trp(9) is important not only for cAMP activation but also for ACTH binding to MC2R.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, a naturally occurring human mutation of Arg 8 in the HFRW sequence results in biologically inactive ACTH (45).”
From ACTH Antagonists (2016) · cites this paper as [45]
Citations
Cites
Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., & Grüters, A. (1998) · Nature Genetics · doi:10.1038/509 · Cited by 1,733
The cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635
Studies on the Physiological Functions of the Melanocortin System
Cone, R. D. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0034 · Cited by 615
Proopiomelanocortin Processing in the Pituitary, Central Nervous System, and Peripheral Tissues
SMITH, A. I., & FUNDER, J. W. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-159 · Cited by 540
Metherell, L. A., Chapple, J. P., Cooray, S., David, A., Becker, C., Rüschendorf, F., Naville, D., Begeot, M., Khoo, B., Nürnberg, P., et al. (2005) · Nature Genetics · doi:10.1038/ng1501 · Cited by 437
ACTH: a short introductory review
Schwyzer, R. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb41843.x · Cited by 394
Gineau, L., Cognet, C., Kara, N., Lach, F. P., Dunne, J., Veturi, U., Picard, C., Trouillet, C., Eidenschenk, C., Aoufouchi, S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61014 · Cited by 307
MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans
Hughes, C. R., Guasti, L., Meimaridou, E., Chuang, C.-H., Schimenti, J. C., King, P. J., Costigan, C., Clark, A. J. L., & Metherell, L. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60224 · Cited by 260
Meimaridou, E., Kowalczyk, J., Guasti, L., Hughes, C. R., Wagner, F., Frommolt, P., Nürnberg, P., Mann, N. P., Banerjee, R., Saka, H. N., et al. (2012) · Nature Genetics · doi:10.1038/ng.2299 · Cited by 258
A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance
Lee, Y. S., Challis, B. G., Thompson, D. A., Yeo, G. S. H., Keogh, J. M., Madonna, M. E., Wraight, V., Sims, M., Vatin, V., Meyre, D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.006 · Cited by 234
Cited by
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
Kühnen, P., Clément, K., Wiegand, S., Blankenstein, O., Gottesdiener, K., Martini, L. L., Mai, K., Blume-Peytavi, U., Grüters, A., & Krude, H. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512693 · Cited by 485
POMC: The Physiological Power of Hormone Processing
Harno, E., Gali Ramamoorthy, T., Coll, A. P., & White, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00024.2017 · Cited by 262
FORGE Canada Consortium: Outcomes of a 2-Year National Rare-Disease Gene-Discovery Project
Beaulieu, C. L., Majewski, J., Schwartzentruber, J., Samuels, M. E., Fernandez, B. A., Bernier, F. P., Brudno, M., Knoppers, B., Marcadier, J., Dyment, D., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.05.003 · Cited by 239
Biologically Inactive Leptin and Early-Onset Extreme Obesity
Wabitsch, M., Funcke, J.-B., Lennerz, B., Kuhnle-Krahl, U., Lahr, G., Debatin, K.-M., Vatter, P., Gierschik, P., Moepps, B., & Fischer-Posovszky, P. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406653 · Cited by 216
MC 1R, the c AMP pathway, and the response to solar UV: extending the horizon beyond pigmentation
García‐Borrón, J. C., Abdel‐Malek, Z., & Jiménez‐Cervantes, C. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12257 · Cited by 187
“…rescues the pigmentation phenotype ofMC1Re/e mice bearing a completely inactive truncated mutant (Healy et al., 2001), patients with mutations in the POMC gene abolishing translation, or interfering with the production or activity of MCs have red hair (Krude et al., 1998; Samuels et al., 2013).”
Background60 YEARS OF POMC: Adrenal and extra-adrenal functions of ACTH
Gallo-Payet, N. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0257 · Cited by 98
“is important not only for cAMP activation but also for ACTH binding to MC2R (Samuels et al. 2013).”
Self-citationMonogenic forms of childhood obesity due to mutations in the leptin gene
Funcke, J., von Schnurbein, J., Lennerz, B. S., Lahr, G., Debatin, K., Fischer‐Posovszky, P., & Wabitsch, M. (2014) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-014-0003-1 · Cited by 109
“For example, cases of biologically inactive protein have been reported for hormones like ACTH, TSH, as well as the leptin-related GH [33-36].”
Backgroundda Fonseca, A. C. P., Mastronardi, C., Johar, A., Arcos-Burgos, M., & Paz-Filho, G. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.026 · Cited by 79
ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?
Frīdmanis, D., Roga, A., & Kloviņš, J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00013 · Cited by 90
“Isolated adrenal cells: ACTH(1124), a competitive antagonist of ACTH(1-39) and ACTH(1-10).”
BackgroundSteroidogenesis—Adrenal Cell Signal Transduction
Gallo‐Payet, N., & Battista, M. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130050 · Cited by 74
Opitz, R., Hitz, M.-P., Vandernoot, I., Trubiroha, A., Abu-Khudir, R., Samuels, M., Désilets, V., Costagliola, S., Andelfinger, G., & Deladoëy, J. (2015) · Endocrinology · doi:10.1210/en.2014-1628 · Cited by 55
“Details forexomesequencing and variant analysis were performed as described in our previous paper (25).”
MethodA pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c
Zempo, H., Kim, S.-J., Fuku, N., Nishida, Y., Higaki, Y., Wan, J., Yen, K., Miller, B., Vicinanza, R., Miyamoto-Mikami, E., et al. (2021) · Aging · doi:10.18632/aging.202529 · Cited by 50
Clark, A. J., Forfar, R., Hussain, M., Jerman, J., McIver, E., Taylor, D., & Chan, L. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00101 · Cited by 49
“Interestingly, a naturally occurring human mutation of Arg 8 in the HFRW sequence results in biologically inactive ACTH (45).”
BackgroundAlpha-Melanocyte-Stimulating Hormone-Mediated Appetite Regulation in the Central Nervous System
Wu, Q., Chen, J., Hua, T., & Cai, J. (2023) · Neuroendocrinology · doi:10.1159/000530804 · Cited by 51
60 YEARS OF POMC: The proopiomelanocortin gene: discovery, deletion and disease
Clark, A. J. L. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0268 · Cited by 40
Gregorič, N., Grošelj, U., Bratina, N., Debeljak, M., Tanšek, M. Ž., Omladič, J. Š., Kovač, J., Battelino, T., Kotnik, P., & Stefanija, M. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.689387 · Cited by 48
“Another girl was reported to have spontaneous earlier normal puberty with late normal timing of menarche (17), indicating slower progressing puberty; however, one of the POMC gene variants in this girl targeted only ACTH and a-MSH and not the other POMCderived peptides.”
BackgroundInfluentialInsights from exome sequencing for endocrine disorders
de Bruin, C., & Dauber, A. N. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.72 · Cited by 38
Heyder, N., Kleinau, G., Szczepek, M., Kwiatkowski, D., Speck, D., Soletto, L., Cerdá‐Reverter, J. M., Krude, H., Kühnen, P., Biebermann, H., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00515 · Cited by 40
“This is further supported by pathogenic findings, where an essential amino acid of the N-terminal ACTH peptide (Arg8Cys) is mutated, causing glucocorticoid deficiency by decreased hormone binding (94).”
BackgroundA Patient with Proopiomelanocortin Deficiency: An Increasingly Important Diagnosis to Make
Çetinkaya, S. Ç., Güran, T., Kurnaz, E., Keskın, M., Sağsak, E., Erdeve, Ş. S., Suntharalingham, J. P., Buonocore, F., Achermann, J. C., & Aycan, Z. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.4638 · Cited by 34
“02 pmol/L; prolactin 390 mIU/L (3-24); follicle-stimulating hormone <3 U/L (0.”
Study of LEP, MRAP2 and POMC genes as potential causes of severe obesity in Brazilian patients
da Fonseca, A. C. P., Abreu, G. D. M., Zembrzuski, V. M., Campos, M., Carneiro, J. R. I., Neto, J. F. N., Magno, F. C. C. M., Rosado, E. L., Bozza, P. T., de Cabello, G. M. K., et al. (2020) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-020-00946-z · Cited by 28
Collen, L. L., Delemer, B., Poitou, C., Vaxillaire, M., Toussaint, B., Dechaume, A., Badreddine, A., Boissel, M., Derhourhi, M., Clément, K., et al. (2023) · Genetics in Medicine · doi:10.1016/j.gim.2023.100857 · Cited by 32
Obesity and Hyperphagia With Increased Defective ACTH: A Novel POMC Variant
van der Valk, E. S., Kleinendorst, L., Delhanty, P. J. D., van der Voorn, B., Visser, J. A., van Haelst, M. M., de Graaff, L. C. G., Huisman, M., White, A. E., Ito, S., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac342 · Cited by 23
Carmalt, J. L., Mortazavi, S., McOnie, R. C., Allen, A. L., & Unniappan, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190796 · Cited by 23
From Bioinactive ACTH to ACTH Antagonist: The Clinical Perspective
Ghaddhab, C., Vuissoz, J., & Deladoëy, J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00017 · Cited by 23
“R8C mutation in the sequence encoding ACTH and α-MSH (26).”
BackgroundInfluentialEarly-Onset Central Diabetes Insipidus due to Compound Heterozygosity for AVP Mutations
Bourdet, K., Vallette-Kasic, S., Deladoëy, J., & Vliet, G. V. (2015) · Hormone Research in Paediatrics · doi:10.1159/000441844 · Cited by 17
Magne, F., Ge, B., Larrivée-Vanier, S., Van Vliet, G., Samuels, M. E., Pastinen, T., & Deladoëy, J. (2016) · Thyroid · doi:10.1089/thy.2016.0009 · Cited by 16
“WES was performed using the Agilent 50 Mb SureSelect exon capture library, followed by 2 · 100 nt paired-end sequencing on the Illumina HiSeq 2000 instrument as described previously (7,15).”
Ericson, M. D., & Haskell‐Luevano, C. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00151 · Cited by 17
“A porcine NPY(1-36) peptide with the Tyr36Phe substitution (corresponding to the rs1369007793 SNP with an additional Met17Leu substitution) decreased affinity at the hY1R and hY2R 13- and 5-fold, respectively (a Tyr36His substitution decreased affinity >2,300- and >220-fold).”
BackgroundMethodInfluentialPigeyre, M., & Meyre, D. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_8 · Cited by 18
Dittmann, M. T., Lakatos, G., Wainwright, J. F., Mokrosiński, J., Cross, E., Farooqi, I. S., Wallis, N. J., Halsey, L. G., Wilson, R. P., O’Rahilly, S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj3823 · Cited by 18
Hsieh, Y.-W., Tsai, Y.-W., Lai, H.-H., Lai, C., Lin, C.-Y., & Her, G. M. (2021) · Biomedicines · doi:10.3390/biomedicines9080941 · Cited by 14
“In fact, novel mutations (Phe144Leu [21] and Arg145Cys [22]) located in the α-MSH domain of the POMC gene were observed to be associated with early-onset obesity.”
BackgroundWhole-Exome Sequencing in Congenital Hypothyroidism Due to Thyroid Dysgenesis
Larrivée-Vanier, S., Jean‐Louis, M., Magne, F., Bui, H., Rouleau, G. A., Spiegelman, D., Samuels, M. E., Kibar, Z., Vliet, G. V., & Deladoëy, J. (2022) · Thyroid · doi:10.1089/thy.2021.0597 · Cited by 13
“The cases and controls were sequenced using the Agilent 50 Mb SureSelect all exon V5 capture library, followed by Illumina base pair (2 · 100 bp) HiSeq 2000 or 2500 sequencing technology, as described previously (23,27).”
MethodFetal and Neonatal Endocrinology
Gevers, E. F., Fisher, D. A., & Dattani, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00145-1 · Cited by 11
Soto-Rivera, C. L., & Majzoub, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00003-9 · Cited by 15
(2013) · Journal of Genomes and Exomes · doi:10.4137/jge.s11378 · Cited by 8
Genetic Profiles in the Obese Population
da Fonseca, A. C. P., Bozza, P. T., & Cabello, P. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_8 · Cited by 10
Ohara, N., Kobayashi, M., Tuchida, M., Koda, R., Yoneoka, Y., & Iino, N. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.922376 · Cited by 6
Diagnosis and management of secondary adrenal crisis
Martel‐Duguech, L., Poirier, J., Bourdeau, I., & Lacroix, A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09877-x · Cited by 8
“Combined CRH and ACTH suppression from chronic exposure to supraphysiologic GC (GIAI) is the most frequent etiology within of SAI, TAI and IAI [41] however it is underdiagnosed; in a retrospective study on 183 patients with GIAI, the diagnosis was made during hospital admission in 71% and in…”
Whole-exome Sequencing: Opportunities in Pediatric Endocrinology
Samuels, M. E., Hasselmann, C., Deal, C., Deladoëy, J., & Vliet, G. V. (2014) · Personalized Medicine · doi:10.2217/pme.13.96 · Cited by 4
Winget, M. D., Ericson, M. D., Freeman, K. T., & Haskell‐Luevano, C. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00198 · Cited by 4
Регуляторные пептиды семейства меланокортинов: биосинтез, рецепция, биологические эффекты
Dodonova, S. A., Белых, А. Е., & Бобынцев, И. И. (2018) · Человек и его здоровье · doi:10.21626/vestnik/2018-1/15 · Cited by 6
A practical approach to diagnosis and treatment in children with primary adrenal insufficiency
Capalbo, D., Illiano, S., Vasaturo, S., Lorello, P., Rotondo, F. R., Mase, R. D., Bizzarri, C., & Salerno, M. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf229 · Cited by 5
Cantara, S., Chiofalo, F., Ciuoli, C., Marzocchi, C., Dotti, M. T., Maccora, C., Castagna, M. G., & Giannini, F. (2018) · AACE Clinical Case Reports · doi:10.4158/accr-2018-0382 · Cited by 3
Molecular evolution of the proopiomelanocortin system in Barn owl species
Löw, K., Ducrest, A., San‐Jose, L. M., Simon, C., Uva, V., Seidah, N. G., Pasquato, A., Kunz, S., & Roulin, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231163 · Cited by 3
Addison’s disease without hyperpigmentation in pediatrics: pointing towards specific causes
Giannakopoulos, A., Sertedaki, A., Efthymiadou, A., & Chrysis, D. (2022) · HORMONES · doi:10.1007/s42000-022-00415-5 · Cited by 2
“showed ACTH resistance caused by an unusual mutation in the POMC gene, localized at a site of the sequence, of which its homologous part in rodents is essential for cAMP activation by melanocortins through their receptors [14].”
BackgroundGaston, L. S., & Majzoub, J. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00013-5 · Cited by 1
Application of Exome Sequencing to Mendelian Disorders and the Emergence of Personalised Medicine
Raszek, M. (2013) · Wiley eBooks · doi:10.1002/9780470015902.a0024617
Rare Diseases: How Genomics has Transformed Thinking, Diagnoses and Hope for Affected Families
Meulien, P., Lasko, P. F., MacKenzie, A., Bell, C., & Boycott, K. M. (2013) · Communications in medical and care compunetics · doi:10.1007/978-3-642-38643-5_3
New Technologies in Pre- and Postnatal Diagnosis
Laberge, A., Karalis, A., Chakraborty, P. K., & Samuels, M. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00053-2
Disorders of the Adrenal Cortex in the Fetus and Neonate
Khattab, A., Narasimhan, M. L., Macdonald, A., Costin, G., & New, M. I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00048-9
Investigating the genetics of equine endocrine dysfunction
Cash, C. M. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.238537
Xing, Y., Achermann, J. C., & Hammer, G. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00017-4 · Cited by 1
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00012-7
Disorders of the Adrenal Cortex in the Fetus and Neonate
Flück, C. E., du Toit, T., & Miller, W. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00035-1
Advanced Technologies in Pre- and Postnatal Diagnosis
Laberge, A., & Samuels, M. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00023-5
Metadata
- Authors
- Samuels, M. E., Gallo-Payet, N., Pinard, S., Hasselmann, C., Magne, F., Patry, L., Chouinard, L., Schwartzentruber, J., René, P., Sawyer, N., Bouvier, M., Djemli, A., Delvin, E., Huot, C., Eugene, D., Deal, C. L., Van Vliet, G., Majewski, J., Deladoëy, J., & FORGE Canada Consortium
- Affiliations
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Université de Sherbrooke (CA)
- McGill University and Génome Québec Innovation Centre (CA)
- Institute for Research in Immunology and Cancer (CA)
- Corresponding author
- Deladoëy, Johnny
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-02
- Volume
- 98
- Issue
- 2
- Pages
- 736-742
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2041292342
- Cited by
- 55
- References
- 28
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 8 · 2013: 3
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (82819_1, MOP11215)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- ACTH resistance, glucocorticoid deficiency, Addison's disease, alpha-melanocyte-stimulating hormone, cAMP signaling, hypoglycemia, compound heterozygosity, novel mutations, immunoassay limitations, children
- MeSH terms
- Addison Disease, Adrenocorticotropic Hormone, alpha-MSH, Child, Preschool, Female, Glucocorticoids, Heterozygote, Homozygote, Humans, Hypoglycemia, Infant, Male, Mutation, Receptor, Melanocortin, Type 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.